PRECIGEN, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.7M | $3.9M | $6.2M | $26.9M | $14.3M |
| Selling, general & administrative | $70.1M | $41.3M | $40.4M | — | — |
| Research and development | $41.3M | $53.1M | $48.6M | — | — |
| Operating expenses | $120.2M | $139.0M | $106.0M | — | — |
| Operating income | -$110.5M | -$135.0M | -$99.8M | — | — |
| Interest expense | $3.9M | $6,000 | $468,000 | — | — |
| Pretax income | -$250.6M | -$128.0M | -$96.4M | -$80.0M | -$111.0M |
| Income tax expense | $3,000 | -$1.8M | -$458,000 | -$189,000 | -$160,000 |
| Net income | -$250.6M | -$126.2M | -$95.9M | $28.3M | -$92.2M |
| Balance Sheet | |||||
| Cash and equivalents | $30.2M | $29.5M | $7.6M | $4.9M | $36.4M |
| Current assets | $115.2M | $102.4M | $68.8M | $118.2M | $156.6M |
| Total assets | $155.5M | $145.3M | $151.0M | $216.0M | $359.9M |
| Current liabilities | $37.3M | $21.5M | $23.0M | $78.6M | $34.6M |
| Total liabilities | $134.6M | $78.5M | $32.5M | $89.7M | $252.5M |
| Total debt | $100.0M | $0 | — | $43.3M | $203.3M |
| Stockholders' equity | $20.9M | $38.5M | $118.5M | $126.3M | $107.3M |
| Cash Flow Statement | |||||
| Cash from operations | -$87.8M | -$68.2M | -$66.9M | -$65.0M | -$55.8M |
| Depreciation and amortization | $3.2M | $4.5M | $6.7M | $10.8M | $13.8M |
| Stock-based compensation | $10.9M | $9.5M | $9.9M | $10.2M | $13.9M |
| Capital expenditure | $2.0M | $8.6M | $1.5M | $4.9M | $7.2M |
| Free cash flow | -$89.8M | -$76.8M | -$68.5M | -$70.0M | -$63.0M |
| Impairments | $3.9M | $7.4M | $10.4M | $482,000 | $0 |
Shares outstanding 356.5M · Free float 59.2%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.